for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Spherix Inc

SPEX.OQ

Latest Trade

2.04USD

Change

-0.03(-1.45%)

Volume

7,052

Today's Range

2.02

 - 

2.10

52 Week Range

1.97

 - 

6.59

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
2.07
Open
2.04
Volume
7,052
3M AVG Volume
1.45
Today's High
2.10
Today's Low
2.02
52 Week High
6.59
52 Week Low
1.97
Shares Out (MIL)
2.35
Market Cap (MIL)
5.13
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q3 2019 Spherix Inc Earnings Release

Latest Developments

More

Spherix Files Preliminary Proxy Statement For The Planned Acquisition Of Assets Of CBM Biopharma

Spherix To Make Investment Of $1 Million In Datchat At A Valuation Of $28 Million

Spherix Announces Adjustment To Datchat Acquisition Consideration

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Spherix Inc

Spherix Incorporated is an intellectual property company that owns patented and unpatented intellectual property. The Company is a patent commercialization company focused on generating revenues from the monetization of intellectual property. The Company acquires intellectual property from patent holders in order to maximize the value of the patent holdings by conducting and managing a licensing campaign. Its activities generally include the acquisition and development of patents through internal or external research and development. In addition, it seeks to acquire existing rights to intellectual property through the acquisition of already issued patents and pending patent applications. Its patent portfolio includes both the United States and foreign patents and pending patent applications in the wireless communications and telecommunication sectors, including data, optical and voice technology, antenna technology, wireless fidelity (Wi-Fi), base station functionality, and cellular.

Industry

Business Services

Contact Info

1 Rockefeller Plz Fl 11

+1.347.3217646

http://www.spherix.com/

Executive Leadership

Robert J. Vander Zanden

Independent Chairman of the Board

Anthony Hayes

Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer, Director

Gregory James Blattner

Director

Eric Weisblum

Director

Tim S. Ledwick

Independent Director

Key Stats

Price To Earnings (TTM)
2.38
Price To Sales (TTM)
183.31
Price To Book (MRQ)
0.45
Price To Cash Flow (TTM)
2.00
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
18.49
Return on Equity (TTM)
16.79

Latest News

BRIEF-Spherix Inc - On May 3, Board Approved An Increase In Size Of Board

* SPHERIX INC - ON MAY 3, 2018, BOARD APPROVED AN INCREASE IN SIZE OF BOARD FROM FOUR MEMBERS TO FIVE - SEC FILING Source: (https://bit.ly/2I2JI8s) Further company coverage:

BRIEF-Spherix Announces Adjustment To Datchat Acquisition Consideration

* SPHERIX ANNOUNCES ADJUSTMENT TO DATCHAT ACQUISITION CONSIDERATION

BRIEF-Spherix Expands Blockchain Investment

* SPHERIX INC - CLOSED INVESTMENT IN THEBIT DAILY LLC, A DEVELOPMENT STAGE MEDIA, EDUCATION PLATFORM FOCUSED ON BLOCKCHAIN AND CRYPTOCURRENCY SPACE Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-DatChat Says Has Agreed To Be Acquired By Spherix Inc

* DATCHAT ISSUES SHAREHOLDER UPDATE ON SPHERIX MERGER AND BLOCKCHAIN DEVELOPMENT.

BRIEF-Spherix Announces Proposed Public Offering Of Common Stock

* SPHERIX ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Spherix To Enter Cyber Security Market Via Datchat Acquisition

* SPHERIX TO ENTER CYBER SECURITY MARKET VIA DATCHAT ACQUISITION Source text for Eikon: Further company coverage:

BRIEF-Spherix Files For Mixed Shelf Offering Of Up To $30 Million

* SPHERIX INC FILES FOR MIXED SHELF OFFERING OF UP TO $30 MILLION -SEC FILING Source text: [http://bit.ly/2CMSd0R] Further company coverage:

BRIEF-Spherix announces pricing of public offering of common stock

* Spherix announces pricing of public offering of common stock

BRIEF-Spherix announces definitive terms reached to acquire controlling interest in Hoth Therapeutics

* Spherix Inc. announces definitive terms reached to acquire controlling interest in Hoth therapeutics, a biopharmaceutical company developing its Biolexa platform to treat skin illness such as eczema.

BRIEF-Spherix announces economic interest acquired in new patent portfolio

* Spherix announces economic interest acquired in new patent portfolio

BRIEF-Spherix Inc issues letter to shareholders

* Monetization partnership with equitable ip has resulted in filing of nine new patent infringement lawsuits against defendants Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up